A U.S. prostate cancer surgeon, Dr. David Samadi is an expert in robotic surgery and robotic prostatectomy, and is the driving force behind the development of international prostate cancer treatment capabilities across the world. The Prostate Cancer Foundation (PCF) is currently working to eliminate prostate cancer beyond U.S.
Since 20 years, PCF is committed to raising funds for prostate cancer research projects globally. It implements PSA screenings, prostate cancer awareness and related technological services.
The newly-established PCF China anticipates hosting ‘The First Annual PCF China Scientific Symposium’ next month at the Peking University Wu Jieping Urology Center. In this event, prostate cancer experts from all over the world will participate to consider the innovative prostate cancer prevention and treatment procedures.
PCF China has been established with intent to eradicate prostate cancer deaths, increasing the patient survival and further improving the availability of PCF worldwide. According to Dr. David Samadi, this expansion will be a powerful support in eradicating prostate cancer not only in the U.S. but also all over the world. It is a global integration of multiple doctors and scientists who contribute to putting an end to prostate cancer.
In addition, Dr.Samadi’s SMART surgery technique (Samadi Modified Advanced Robotic Technique) is a high precision robotic surgery procedure that effectively removes cancerous prostates with minimal post operative complexities. This innovative technique has gained attention from all over the world. This procedure provides dual benefits, meaning it offers innovative treatment and prolongs the patients’ life span.